Insulet (NASDAQ:PODD) reported Q1 EPS of $0.40, $0.17 better than the analyst estimate of $0.23. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $288.19 million.
GUIDANCE:
For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.